Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Pulse Biosciences, Inc. (NASDAQ: PLSE).

Full DD Report for PLSE

You must become a subscriber to view this report.


Recent News from (NASDAQ: PLSE)

Robbins Arroyo LLP Is Investigating the Officers and Directors of Pulse Biosciences, Inc. (PLSE) on Behalf of Shareholders
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Pulse Biosciences, Inc. (NasdaqCM: PLSE) breached their fiduciary duties to shareholders. On July 31, 2018, Pulse disclosed that it had received subpoenas from the U.S. Securities and ...
Source: Business Wire
Date: August, 13 2018 16:01
Pulse Biosciences Grants Equity Incentive Awards to New Employees
Pulse Biosciences, Inc. (NASDAQ:PLSE), a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation (NPS) platform, announced today that the Compensation Committee of the company’s Board of Directors granted non-qualified stock...
Source: Business Wire
Date: August, 03 2018 16:50
Pulse Biosciences Inc.'s (PLSE) CEO Darrin Uecker on Q2 2018 Results - Earnings Call Transcript
Pulse Biosciences, Inc. (PLSE) Q2 2018 Earnings Conference Call July 31, 2018 04:30 pm ET Executives Brian Dow - Senior Vice President and Chief Financial Officer Darrin Uecker - President and Chief Executive Officer Presentation Operator Good day, ladies and gentlemen an...
Source: SeekingAlpha
Date: July, 31 2018 22:34
Pulse Biosciences reports Q2 results
Pulse Biosciences (NASDAQ: PLSE ): Q2 EPS of -$0.54 More news on: Pulse Biosciences, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: July, 31 2018 16:03
Pulse Biosciences Quarterly Investor Conference Call
Conference call today at 1:30 p.m. PDT / 4:30 p.m. EDT Pulse Biosciences, Inc. (Nasdaq: PLSE), a clinical stage electroceutical company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation (NPS) platform, today reported recent corporate developme...
Source: Business Wire
Date: July, 31 2018 16:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-1413.9313.6914.371613.6050,770
2018-08-2914.2214.0814.4513.7120,901
2018-08-2813.6714.0914.1413.425127,657
2018-08-2713.8713.6214.0313.5031,591
2018-08-2414.2713.8914.32513.7529,396

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-079,68212,97574.6204Short
2018-12-0610,04318,19755.1904Short
2018-12-0410,52813,40978.5144Short
2018-12-0313,71325,38554.0201Short
2018-11-303,55815,16023.4697Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on PLSE.


About Pulse Biosciences, Inc. (NASDAQ: PLSE)

Logo for Pulse Biosciences, Inc. (NASDAQ: PLSE)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $256,322,638 - 05/18/2018
  • Issue and Outstanding: 16,841,172 - 02/28/2018

 


Recent Filings from (NASDAQ: PLSE)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 31 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 31 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: July, 31 2018
Filing Type: 8-K12BFiling Source: edgar
Filing Date: June, 18 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 23 2018
Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: May, 22 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: May, 21 2018
Simplified registration form
Filing Type: S-3Filing Source: edgar
Filing Date: May, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 08 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 08 2018

 

 


Daily Technical Chart for (NASDAQ: PLSE)

Daily Technical Chart for (NASDAQ: PLSE)


Stay tuned for daily updates and more on (NASDAQ: PLSE)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: PLSE)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in PLSE is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of PLSE and does not buy, sell, or trade any shares of PLSE. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/